Quantifying Renal Allograft Loss Following Early Antibody-Mediated Rejection-Reference-Cited by-同舟云学术

Quantifying Renal Allograft Loss Following Early Antibody-Mediated Rejection

Published:2015-01-21 Issue:2 Volume:15 Page:489-498
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Orandi B. J.¹,Chow E. H. K.¹,Hsu A.¹,Gupta N.¹,Van Arendonk K. J.¹,Garonzik-Wang J. M.¹,Montgomery J. R.¹,Wickliffe C.¹,Lonze B. E.¹,Bagnasco S. M.²,Alachkar N.³,Kraus E. S.³,Jackson A. M.³,Montgomery R. A.¹,Segev D. L.¹

Affiliation:

1. Departments of Surgery; Johns Hopkins University School of Medicine; Baltimore MD

2. Departments of Pathology; Johns Hopkins University School of Medicine; Baltimore MD

3. Departments of Medicine; Johns Hopkins University School of Medicine; Baltimore MD

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference32 articles.

1. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients;Bagnasco;Transplantation,2014

2. Incompatible live-donor kidney transplantation in the United States: Results of a national survey;Garonzik Wang;Clin J Am Soc Nephrol,2011

3. Center-level utilization of kidney paired donation;Massie;Am J Transplant,2013

4. Desensitization in HLA-incompatible kidney recipients and survival;Montgomery;N Engl J Med,2011

5. Kidney paired donation and optimizing the use of live donor organs;Segev;JAMA,2005

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

2. Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant;Transplantation;2024-08-20

3. Blood Gene Signature as a Biomarker for Subclinical Kidney Allograft Rejection: Where Are We?;Transplantation;2024-06-13

4. Serum IL-6 predicts risk of kidney transplant failure independently of immunological risk;Transplant Immunology;2024-06

5. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor‐specific anti HLA antibodies;HLA;2024-06